PReS13-SPK-1292: Gut microbiome and metabolism

by Tilg, H
Published 2013

Diet and relapsing ulcerative colitis: take off the meat?

by Tilg, H, Kaser, A
Published 2004

Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?

by Tilg, H, Kaser, A
Published 2005

Interferon-alpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway

by Kaser, A, Enrich, B, Ludwiczek, O, Vogel, W, Tilg, H
Published 1999

Cachexia and tumour necrosis factor-alpha in cytomegalovirus infection.

by Tilg, H, Vogel, W, Herold, M, Aulitzky, W E, Huber, C
Published 1991

Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease

by LUDWICZEK, O, VANNIER, E, BORGGRAEFE, I, KASER, A, SIEGMUND, B, DINARELLO, C A, TILG, H
Published 2004

Serum neopterin concentrations in chronic liver disease.

by Wilmer, A, Nölchen, B, Tilg, H, Herold, M, Pechlaner, C, Judmaier, G, Dietze, O, Vogel, W
Published 1995

Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).

by Aulitzky, W E, Grosse-Wilde, H, Westhoff, U, Tilg, H, Aulitzky, W, Gastl, G, Herold, M, Huber, C
Published 1991

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

by Moschen, A R, Kaser, A, Enrich, B, Ludwiczek, O, Gabriel, M, Obrist, P, Wolf, A M, Tilg, H
Published 2005

Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case repo...

by Al-Zoairy, R., Viveiros, A., Zoller, H., Schneeberger, S., Oberhuber, G., Gunsilius, E., Tilg, H., Wolf, D., Rudzki, J. D.
Published in J Med Case Rep (2020)

Adiponectin and its receptors in non-alcoholic steatohepatitis

by Kaser, S, Moschen, A, Cayon, A, Kaser, A, Crespo, J, Pons-Romero, F, Ebenbichler, C F, Patsch, J R, Tilg, H
Published 2005

Interferon-α induces interleukin-18 binding protein in chronic hepatitis C patients

by KASER, A, NOVICK, D, RUBINSTEIN, M, SIEGMUND, B, ENRICH, B, KOCH, R O, VOGEL, W, KIM, S H, DINARELLO, C A, TILG, H
Published 2002

In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharides (LPS)

by Troppmair, J., Nachbaur, K., Herold, M., Aulitzky, W., Tilg, H., Gastl, G., Bieling, P., Kotlan, B., Flener, R., Mull, B., Aulitzky, W. O., Rokos, H., Huber, Ch.
Published 1988

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

by Tilg, H, Vogelsang, H, Ludwiczek, O, Lochs, H, Kaser, A, Colombel, J-F, Ulmer, H, Rutgeerts, P, Krüger, S, Cortot, A, D’Haens, G, Harrer, M, Gasche, C, Wrba, F, Kuhn, I, Reinisch, W
Published 2003

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

by Stange, E F, Travis, S P L, Vermeire, S, Beglinger, C, Kupcinskas, L, Geboes, K, Barakauskiene, A, Villanacci, V, Von Herbay, A, Warren, B F, Gasche, C, Tilg, H, Schreiber, Stefan W, Schölmerich, J, Reinisch, W
Published 2006

Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ

by Tilg, H, van Montfrans, C, van den Ende, A, Kaser, A, van Deventer, S J H, Schreiber, S, Gregor, M, Ludwiczek, O, Rutgeerts, P, Gasche, C, Koningsberger, J C, Abreu, L, Kuhn, I, Cohard, M, LeBeaut, A, Grint, P, Weiss, G
Published 2002